Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.17% | 135.57 | 0.0% | $895.14m | |
| AMGN | Amgen, Inc. | 0.36% | 253.95 | 1.5% | $855.01m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 64.47 | 1.0% | $544.83m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.32% | 270.50 | 1.9% | $489.26m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.05% | 683.77 | 2.6% | $434.75m | |
| ILMN | Illumina, Inc. | 1.76% | 247.85 | 3.3% | $318.97m | |
| NVAX | Novavax, Inc. | -1.08% | 46.56 | 75.7% | $255.64m | |
| BIIB | Biogen, Inc. | 0.00% | 204.22 | 1.8% | $232.70m | |
| BNTX | BioNTech SE | 0.53% | 158.99 | 0.0% | $212.11m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 2.10 | 0.7% | $146.80m | |
| EXAS | EXACT Sciences Corp. | 2.21% | 50.96 | 17.7% | $131.02m | |
| TECH | Bio-Techne Corp. | 0.00% | 365.32 | 4.5% | $100.31m | |
| TXG | 10X Genomics, Inc. | 0.00% | 47.35 | 0.0% | $95.11m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.00% | 78.86 | 4.2% | $94.54m | |
| CRSP | CRISPR Therapeutics AG | 1.87% | 56.26 | 0.6% | $81.90m |
Company Profile
INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.